Disseminated Intravascular Coagulation

Consultative Hemostasis and Thrombosis

Volumn , Issue , 2007, Pages 183-198

  LaBelle, Carrie ^a   Kitchens, Craig S ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 68249152912     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-141602401-9.10012-4     Document Type: Chapter

References (109)

1. DG McKay (1965) DIC: An Intermediary Mechanism of Disease New York: Harper‐Hoeber 493.
2. J Hunter (1817) A Treatise on the Blood, Inflammation, and Gun‐Shot Wounds Philadelphia: Webster
3. HMD DeBlainville (1834) Injection de matiere cerebrale dans les veins. Gaz Med Paris (ser 2) 2 524-567.
4. B Nauyn (1873) Unterschungen Ober Blutgirinnung Im Lebenden Tiere und Ihre Folgen. Arch Exp Pathol Pharmak 1 1.
5. P Foa and P Pellacani (1884) Sul Fermento Fibrinogeno: Sulle Azioni Tossiche, Escercitate da Alcuni Organi Fresch. Arch Sci Med (Torino) 7 113.
6. LD Wooldridge (1893) V Horsley, E Starling (Eds) On the Chemistry of the Blood and Other Scientific Papers London: Kegan, Paul, Trench, Trubner, and Co
7. CA Mills (1921) The action of tissue extracts in the coagulation of blood. J Biol Chem 46 167-192.
8. JR Krevans, DP Jackson, CL Conley, et al. (1957) The nature of the hemorrhagic disorders accompanied by hemolytic transfusions in man. Blood 12 834-843.
9. C Schneider (1959) Etiology of fibrinopenia: Fibrination defibrination. Ann NY Acad Sci 75 634-675.
10. C Merskey, GJ Kleiner and AJ Johnson (1966) Quantitative estimation of split products of fibrinogen in human serum, relation to diagnosis and treatment. Blood 28 1-18.
11. VJ Marder, HR Shulman and WR Carroll (1969) High molecular weight derivatives of human fibrinogen produced by plasmin. I. Physicochemical and immunological characterization. J Biol Chem 244 211-219.
12. JJ Corrigan (1968) Changes in the blood coagulation system associated with septicemia. N Engl J Med 279 851-856.
13. B Bull, M Rubenberg, J Dacie, et al. (1968) Microangiopathic haemolytic anemia: Mechanisms of red‐cell fragmentation. Br J Haematol 14 643-652.
14. RW Colman, SJ Robboy and JD Minna (1972) DIC: An approach. Am J Med 52 679-689.
15. C Merskey (1973) Defibrination syndrome or…? Blood 41 599-603.
16. MJ Mant and EG King (1979) Severe acute DIC. Am J Med 67 557-563.
17. GH Sack, J Levin and WR Bell (1977) Trousseau's syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: Clinical, pathologic and therapeutic features. Medicine (Baltimore) 56 1-37.
18. K Okajima, Y Sakamoto and M Uchiba (2000) Heterogenity in the incidence and clinical manifestations of disseminated intravascular coagulation. Am J Hematol 65 215-222.
19. N Semeraro and M Colucci (1997) Tissue factor in health and disease. Thromb Haemost 78 759-764.
20. C Gabay and J Kushner (1999) Acute‐phase proteins and other systemic responses to inflammation. N Engl J Med 340 448-454.
21. S Gando, T Kameve, S Nanzaki, et al. (1996) Disseminated intravascular coagulation is a frequent complication of systemic inflammatory response syndrome. Thromb Haemost 75 224-228.
22. AF Suffredini, PC Harpel and JE Parrillo (1989) Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects. N Engl J Med 320 1165-1172.
23. JM Carr, M McKinney and J McDonagh (1989) Diagnosis of disseminated intravascular coagulation: Role of D‐dimer. Am J Clin Pathol 91 280-287.
24. G Mombelli, G Fiori, R Monotto, et al. (1993) Fibrinopeptide A in liver cirrhosis: Evidence against a major contribution of disseminated intravascular coagulation to coagulopathy of chronic liver disease. J Lab Clin Med 121 83-90.
25. CS Kitchens (1992) Hemostatic aspects of envenomation by North American snakes. Hematol Oncol Clin North Am 6 1189-1195.
26. D Deykin (1966) The role of the liver in serum‐induced hypercoagulability. J Clin Invest 45 256-263.
27. PM Sandset, BJ Warn‐Cramer, SL Maki, et al. (1991) Immunodepletion of extrinsic pathway inhibitor sensitizes rabbits to endotoxin‐induced intravascular coagulation and the generalized Shwartzman reaction. Blood 78 1496-1502.
28. RA Pixley, R De La Cadena, JD Page, et al. (1993) The contact system contributes to hypotension but not disseminated intravascular coagulation in lethal bacteremia: In vivo use of a monoclonal anti–factor XII antibody to block contact activation in baboons. J Clin Invest 92 61-68.
29. M Levi and H ten Cate (1999) Disseminated intravascular coagulation. N Engl J Med 341 586-592.
30. H Tapper and H Herwald (2000) Modulation of hemostatic mechanisms in bacterial infectious diseases. Blood 96 2329-2337.
31. SH Goodnight (1974) Defibrination after brain‐tissue destruction: A serious complication of head injury. N Engl J Med 290 1043-1047.
32. JJ Van der Sande, JJ Emiss and J Lindeman (1981) Intravascular coagulation: A common phenomenon in minor experimental head injury. J Neurosurg 54 21-25.
33. JJ Van der Sande, JJ Veltkamp, RJ Boekhout‐Mussert, et al. (1981) Hemostasis and computerized tomography in head injury: Their relationship to clinical features. J Neurosurg 55 718-724.
34. JD Olson, HH Kaufman, J Moake, et al. (1989) The incidence and significance of hemostatic abnormalities in patients with head injuries. Neurosurgery 24 825-832.
35. BM Selladurai, M Vickneswaran, S Duraisamy, et al. (1997) Coagulopathy in acute head injury: A study of its role as a prognostic indicator. Br J Neurosurg 11 398-404.
36. Y Fujii, S Takeuchi, A Harada, et al. (2001) Hemostatic activation in spontaneous intracranial hemorrhage. Stroke 32 883-890.
37. MM Jelenska, J Szmidt, K Bojakowski, et al. (2004) Compensated activation of coagulation in patients with abdominal aortic aneurysm: Effects of heparin treatment prior to elective surgery. Thromb Haemost 92 997-1002.
38. J Oba, N Shiiya, Y Matsui, et al. (1995) Preoperative disseminated intravascular coagulation (DIC) associated with aortic aneurysm: Does it need to be corrected before surgery? Surg Today 25 1011-1014.
39. DM Aboulafia and ED Aboulafia (1996) Aortic aneurysm–induced disseminated intravascular coagulation. Ann Vasc Surg 10 396-405.
40. HR Brady and GG Singer (1995) Acute renal failure. Lancet 346 1533-1540.
41. R Thadhani, M Pascual and JV Bonventre (1996) Acute renal failure. N Engl J Med 334 1448-1460.
42. N Pertuiset and JP Grunfeld (1994) Acute renal failure in pregnancy. Baillieres Clin Obstet Gynaecol 8 333-351.
43. D Kleinknecht, JP Grunfeld, PC Gomez, et al. (1973) Diagnostic procedures and long‐term prognosis in bilateral renal cortical necrosis. Kidney Int 4 390-400.
44. MS Marotto, PC Marotto, J Sztajnbok and AC Seguro (1997) Outcome of acute renal failure in meningococcemia. Ren Fail 19 807-810.
45. JP Brozna (1990) Shwartzman reaction. Semin Thromb Hemost 16 326-332.
46. AR Kitching, YZ Kong, XR Huang, et al. (2003) Plasminogen activator inhibitor‐1 is a significant determinant of renal injury in experimental crescentic glomerulonephritis. J Am Soc Nephrol 14 1487-1495.
47. R Montes, PH Declerck, A Calvo, et al. (2000) Prevention of renal fibrin deposition in endotoxin‐induced DIC through inhibition of PAI‐1. Thromb Haemost 84 65-70.
48. M Francois, I Tostivint, L Mercadal, et al. (2000) MR imaging features of acute bilateral renal cortical necrosis. Am J Kidney Dis 35 745-748.
49. Y Gielchinsky, N Rojansky, SJ Fasouliotis and Y Ezra (2002) Placenta accreta—Summary of 10 years: A survey of 310 cases. Placenta 23 210-214.
50. L Hudon, MA Belfort and DR Broome (1998) Diagnosis and management of placenta percreta: A review. Obstet Gynecol Surv 53 509-517.
51. F Abbas, J Talati, S Wasti, et al. (2000) Placenta percreta with bladder invasion as a cause of life threatening hemorrhage. J Urol 164 1270-1274.
52. P Merviel, D Evain‐Brion, JC Challier, et al. (2001) The molecular basis of embryo implantation in humans. Zentralbl Gynakol 123 328-339.
53. P Taipale, MR Orden, M Berg, et al. (2004) Prenatal diagnosis of placenta accrete and percreta with ultrasonography, color Doppler, and magnetic resonance imaging. Obstet Gynecol 104 537-540.
54. HP Dinkel, P Durig, P Schnatterbeck and J Triller (2003) Percutaneous treatment of placenta percreta using coil embolization. J Endovasc Ther 10 158-162.
55. F Alkazaleh, M Geary, J Kingdom, et al. (2004) Elective non‐removal of the placenta and prophylactic uterine artery embolization postpartum as a diagnostic imaging approach for the management of placenta percreta: A case report. J Obstet Gynaecol Can 26 743-746.
56. D Clement, G Kayem and D Cabrol (2004) Conservative treatment of placenta percreta: A safe alternative. Eur J Obstet Gynecol Reprod Biol 114 108-109.
57. W Henrich, I Fuchs, T Ehrenstein, et al. (2002) Antenatal diagnosis of placenta percreta with planned in situ retention and methotrexate therapy in a woman infected with HIV. Ultrasound Obstet Gynecol 20 90-93.
58. K Butt, A Gagnon and MF Delisle (2002) Failure of methotrexate and internal iliac balloon catheterization to manage placenta percreta. Obstet Gynecol 99 981-982.
59. T Barbui, G Finazzi and A Falanga (1998) The impact of all‐trans‐retinoic acid on the coagulopathy of acute promyelocytic leukemia. Blood 91 3093-3102.
60. MA Sanz, MS Tallman and F Lo‐Coco (2005) Tricks of the trade for the appropriate management of newly diagnosed acute promyelocytic leukemia. Blood 105 3019-3025.
61. HC Kwann, J Wang and LN Boggio (2002) Abnormalities in hemostasis in acute promyelocytic leukemia. Hematol Oncol 20 33-41.
62. R Ohno, N Asou and K Ohnishi (2003) Treatment of acute promyelocytic leukemia: Strategy toward further increase of cure rate. Leukemia 17 1454-1463.
63. RL Bick (1998) Disseminated intravascular coagulation: Pathophysiological mechanisms and manifestations. Semin Thromb Hemost 24 3-18.
64. F Reister, W Heyl and W Rath (1997) Coagulation disorders in pregnancy. Biomed Prog 10 62-67.
65. H Wada, Y Wakita, T Nakase, et al. (1995) Outcome of disseminated intravascular coagulation in relation to the score when treatment was begun. Thromb Haemost 74 848-852.
66. EF Mammen (1998) The haematological manifestations of sepsis. J Antimicrob Chemother 41 17-24.
67. FB Taylor Jr, C.H. Toh C‐H, WK Hoots, et al. (2001) Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 86 1327-1330.
68. CH Toh and WK Hoots (2007) on behalf of the SSC on Disseminated Intravascular Coagulation of the ISTH The scoring system of the scientific and standardisation committee on disseminated intravascular coagulation of the international society on thrombosis and haemostasis: A 5‐year overview. J Thromb Haemost 5 604-606.
69. Z Ben‐Ari, E Osman, RA Hutton, et al. (1999) Disseminated intravascular coagulation in liver cirrhosis: Fact or fiction? Am J Gastroenterol 94 2977-2982.
70. CS Kitchens (2005) To bleed or not to bleed? Is that the question for the PTT? J Thromb Haemost 3 2605-2611.
71. JF Hardy, P De Moerloose, M Samama, et al. (2004) Massive transfusion and coagulopathy: Pathophysiology and implications for clinical management. Can J Anaesth 51 293-310.
72. N Cosgriff, EE Moore, A Sauaia, et al. (1997) Predicting life‐threatening coagulopathy in the massively transfused trauma patient: Hypothermia and acidosis revisited. J Trauma 42 857-861.
73. L MacIntyre and PC Hebert (2002) To transfuse or not in trauma patients: A presentation of the evidence and rationale. Curr Opin Anesthesiol 15 179-185.
74. JH Stone (1998) HELLP syndrome: Hemolysis, elevated liver enzymes, and low platelets. JAMA 280 559-562.
75. CS Kitchens (1998) Thrombotic storm: When thrombosis begets thrombosis. Am J Med 104 381-385.
76. RS Egerman and RM Sibai (1999) Imitators of preeclampsia and eclampsia. Clin Obstet Gynecol 42 551-562.
77. PA Van Dam, M Renier, M Baekelandt, et al. (1989) Disseminated intravascular coaglation and the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia. Obstet Gynecol 73 97-102.
78. K De Boer, HR Buller, JW ten Cate, et al. (1991) Coagulation studies in the syndrome of haemolysis, elevated liver enzymes and low platelets. Br J Obstet Gynaecol 98 42-47.
79. A Trousseau (1865) Phlegmasia alba dolens: Clinique Medicale de l'Hotel‐Dieu de Paris. The New Sydenham Society 3 94.
80. N Callander and SI Rapaport (1993) Trousseau's syndrome. West J Med 158 364-371.
81. NS Callander, N Varki and LV Mohan (1992) Immunohistochemical identification of tissue factor in solid tumors. Cancer 70 1194-1201.
82. C Shigemori, H Wada, K Matsumoto, et al. (1998) Tissue factor expression and metastatic potential of colorectal cancer. Thromb Haemost 80 894-898.
83. WF Hickey, MB Garnick, IC Henderson, et al. (1982) Primary cerebral venous thrombosis in patients with cancer: A rarely diagnosed paraneoplastic syndrome. Am J Med 73 740-750.
84. SH Tasi, CH Juan, MS Dai and WY Kao (2004) Trousseau's syndrome related to adenocarcinoma of the colon and cholangiocarcinoma. Eur J Neurol 11 493-496.
85. EE Ridgon (2000) Trousseau's syndrome and acute arterial thrombosis. Cardiovasc Surg 8 214-218.
86. CP Alderman, AF McClure, HP Jersmann and SD Scott (1995) Continuous subcutaneous heparin infusion for treatment of Trousseau's syndrome. Ann Pharmacother 29 710-713.
87. D Walsh‐McMonagle and D Green (1997) Low‐molecular‐weight heparin in the management of Trousseau's syndrome. Cancer 80 649-655.
88. AC Andreescu, M Cushman, JM Hammond and ME Wood (2001) Trousseau's syndrome treated with long‐term subcutaneous lepirudin (case report and review of the literature). J Thromb Thrombolysis 11 33-37.
89. WR Bell, NF Starksen, S Tong, et al. (1985) Trousseau's syndrome: Devastating coagulopathy in the absence of heparin. Am J Med 79 423-430.
90. EM Woerner and RL Rowe (1988) Trousseau's syndrome. Am Fam Physician 38 195-201.
91. K Meijer, WM Smid, S Geerards, et al. (1998) Hyperfibrinogenolysis in disseminated adenocarcinoma. Blood Coagul Fibrinolysis 9 279-283.
92. JS Menell, GM Cesarman, AT Jacovina, et al. (1999) Annexin II and bleeding in acute promyelocytic leukemia. N Engl J Med 340 994-1004.
93. P Kallis, JA Tooze, S Talbot, et al. (1994) Aprotinin inhibits fibrinolysis, improves platelet adhesion and reduces blood loss. Eur J Cardio‐thorac Surg 8 315-323.
94. JF Boylan, JR Klinck, AN Sandler, et al. (1996) Tranexamic acid reduces blood loss, transfusion requirements, and coagulation factor use in primary orthotopic liver transplantation. Anesthesiology 85 1043-1048.
95. H Wada, Y Mori, K Okabayashi, et al. (2003) High plasma fibrinogen level is associated with poor clinical outcome in DIC patients. Am J Hematol 72 1-7.
96. MS Rangel‐Frausto, D Pittet, M Costigan, et al. (1995) The natural history of the systemic inflammatory response syndrome (SIRS). JAMA 273 117-123.
97. S Gando, Y Nakanishi and I Tedo (1995) Cytokines and plasminogen activator inhibitor‐1 in posttrauma disseminated intravascular coagulation: Relationship to multiple organ dysfunction syndrome. Crit Care Med 23 1835-1842.
98. JT Crawley, JK Lam, JB Rance, et al. (2005) Proteolytic inactivation of ADAMTS13 by thrombin and plasmin. Blood 105 1085-1093.
99. T Ono, J Mimuro, S Madoiwa, et al. (2006) Severe secondary deficiency of von Willebrand factor‐cleaving protease (ADAMTS13) in patients with sepsis‐induced disseminated intravascular coagulation: Its correlation with development of renal failure. Blood 107 528-534.
100. MJ Wells, WP Sheffield and MA Blajchman (1999) The clearance of thrombin–antithrombin and related serpin–enzyme complexes from the circulation: Role of various hepatocyte receptors. Thromb Haemost 81 325-327.
101. MC Minnema, CK Chang, PM Jansen, et al. (2000) Recombinant human antithrombin III improves survival and attenuates inflammatory responses in baboons lethally challenged with Escherichia coli. Blood 95 1117-1123.
102. F Baudo, TK Caimi, F de Cataldo, et al. (1998) Antithrombin III (ATIII) replacement therapy in patients with sepsis and/or postsurgical complications: A controlled double‐blind, randomized, multicenter study. Intensive Care Med 24 336-342.
103. D Inthorn, JN Hoffmann, WH Hartl, et al. (1997) Antithrombin III supplementation in severe sepsis: Beneficial effects on organ dysfunction. Shock 8 328-334.
104. AP Wheeler and GR Bernard (1999) Treating patients with severe sepsis. N Engl J Med 340 207-214.
105. GR Bernard, J.L. Vincent J‐L, P.F. Laterre P‐F, et al. (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344 699-709.
106. M Saito, H Asakura, H Jokaji, et al. (1995) Recombinant hirudin for the treatment of disseminated intravascular coagulation in patients with haematological malignancy. Blood Coagul Fibrinolysis 6 60-64.
107. S Segal, IY Shemesh, R Blumenthal, et al. (2003) Treatment of obstetric hemorrhage with recombinant activated factor VII (rFVIIa). Arch Gynecol Obstet 268 266-267.
108. S Sallah, A Husain and NP Nguyen (2004) Recombinant activated factor VII in patients with cancer and hemorrhagic disseminated intravascular coagulation. Blood Coagul Fibrinolysis 15 577-582.
109. JD Morenski, JD Tobias and DF Jimenez (2003) Recombinant activated factor VII for cerebral injury–induced coagulopathy in pediatric patients: Report of three cases and review of the literature. J Neurosurg 98 611-616.